A Phase 4 interventional study of Tamsulosin and Placebo Oral Capsule in Postoperative Urinary Retention, sponsored by Ascension Health. Completed. Open to male participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-30.
Sponsored by Ascension Health · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies testing tamsulosin in Urinary Retention — 7 open to participants now, 7 under way, 2 of them phase 3. Tamsulosin · Urinary Retention.
Among the 26 studies testing tamsulosin in Urinary Retention, this one is the 4th largest by enrollment, is one of 5 that started in 2017, is one of 8 in phase 4, and was the 8th registered.
242 studies on the registry are indexed under Urinary Retention; 43 are open to participants now.
Browse Urinary Retention studies →7 of the 26 studies testing tamsulosin in Urinary Retention are open now, in 3 countries. Recruiting first, the newest first:
Mayo Clinic · Sites in United States
Ages 35+
TriHealth Inc. · Sites in United States
Ages 18+ · Women only
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 40+
CHU de Quebec-Universite Laval · Sites in Canada
Ages 18+ · Men only · Healthy volunteers
Hackensack Meridian Health · Sites in United States
Ages 55+ · Men only
By country, each count listing its studies:
Tamsulosin: first FDA approval 1997 (FLOMAX). What it is approved for, and how studies give it, is on its page →
Of the 30 Urinary Retention studies recruiting now, 22 (73%) set no upper age limit and 5 (17%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.
This study: 30 Years and older · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 6 · Phase 3 8 · Phase 4 8
First in 2007; this study’s year is marked. 5 started in 2017.
This study's enrollment of 210 is above the median of 89 across 188 interventional studies indexed under Urinary Retention.
Median enrollment 136 across the 26 interventional studies. Of the 16 that completed or were terminated, 9 (56%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 26 have an industry lead sponsor. The 10 most frequent:
Ascension Health is the lead sponsor of 21 studies on the registry; 3 are open to participants now.
Ascension Health has 1 study filed under Urinary Retention — fewer than ten, so there is no comparison to draw.
4 of the studies testing tamsulosin in Urinary Retention that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05941806Phase 3CHU de Quebec-Universite LavalProphylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection | 2027-07-30 |
| NCT04597372Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery | 2026-12 |
| NCT07174349Mayo ClinicUroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery | 2027-01-31 |
| NCT05657990Hackensack Meridian HealthPost Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 26 studies testing tamsulosin in Urinary Retention, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Double blinded, randomized controlled prospective study looking at 2 preoperative doses of Tamsulosin an alpha-adrenergic blocker in preventing post-operative urinary retention. A previous study was conducted called "Effectiveness of tamsulosin inprevention of postoperative urinary retention: a randomized double-blind-placebo controlled study" This study involved a tertiary care center involving mostly urological surgical procedures. We look to specifically look at inguinal hernia surgeries in males. The aim of this study is to compare the prophylactic effect of tamsulosin with placebo on postoperative urinary retention. The drug is FDA approved for benign prostatic hypertrophy and urinary retention. It is on formulary at Genesys. Currently there is no standard procedure of prophylactic tamsulosin for urinary retention. Most often post operative patients are given tamsulosin to augment smooth muscle relaxation and spontaneous voiding if the patient is having urinary retention post operatively. We often straight catheterize patients once and start tamsulosin with the goal of avoiding urinary retention and future straight catheterizations or placement of foley catheters
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Tamsulosin 0.4mg given the night before surgery and another dose the day of surgery in the morning.
Drug: Tamsulosin
Placebo medication given the night before surgery and another dose the day of surgery in the morning
Drug: Placebo Oral Capsule
Also known as: Flomax
number of Urinary Retention
If patients have urinary retention post operatively
Time frame: within 72 hours of surgery
placebo vs tamsulosin
Time frame: within 72 hours of surgery
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2017 to primary completion in Nov 2018, 22 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tamsulosin
Ascension Health